Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Consolidated Net Income (2021 - 2025)

Historic Consolidated Net Income for Dare Bioscience (DARE) over the last 5 years, with Q3 2025 value amounting to -$3.7 million.

  • Dare Bioscience's Consolidated Net Income rose 2155.79% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.4 million, marking a year-over-year increase of 2530.02%. This contributed to the annual value of -$23.5 million for FY2024, which is 2420.31% up from last year.
  • As of Q3 2025, Dare Bioscience's Consolidated Net Income stood at -$3.7 million, which was up 2155.79% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Consolidated Net Income registered a high of $384322.0 during Q2 2022, and its lowest value of -$16.2 million during Q4 2022.
  • In the last 5 years, Dare Bioscience's Consolidated Net Income had a median value of -$7.1 million in 2022 and averaged -$7.1 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 10419.43% in 2022, then plummeted by 243901.68% in 2023.
  • Over the past 5 years, Dare Bioscience's Consolidated Net Income (Quarter) stood at -$9.5 million in 2021, then plummeted by 70.08% to -$16.2 million in 2022, then soared by 68.14% to -$5.2 million in 2023, then dropped by 4.19% to -$5.4 million in 2024, then surged by 31.85% to -$3.7 million in 2025.
  • Its last three reported values are -$3.7 million in Q3 2025, -$3.8 million for Q2 2025, and -$4.6 million during Q1 2025.